Your browser doesn't support javascript.
loading
Does the addition of whole-body MRI to routine imaging influence real-world treatment decisions in metastatic breast cancer?
Bhaludin, Basrull N; Tunariu, Nina; Senthivel, Nishanthi; Babiker, Amna; Soneji, Neil D; Hujairi, Nabil; Sharma, Bhupinder; McGrath, Sophie E; Okines, Alicia F; Ring, Alistair E; Messiou, Christina; Downey, Kate; Koh, Dow-Mu.
Afiliação
  • Bhaludin BN; Department of Radiology, The Royal Marsden Hospital, 203 Fulham Rd, London, SW3 6JJ, England, UK. basrull.bhaludin@rmh.nhs.uk.
  • Tunariu N; Department of Radiology, The Royal Marsden Hospital, Downs Rd, Sutton, SM2 5PT, England, UK.
  • Senthivel N; Institute of Cancer Research, London, England, UK.
  • Babiker A; Department of Medicine - Breast Unit, The Royal Marsden Hospital, Downs Rd, Sutton, SM2 5PT, England, UK.
  • Soneji ND; Department of Medicine - Breast Unit, The Royal Marsden Hospital, Downs Rd, Sutton, SM2 5PT, England, UK.
  • Hujairi N; Department of Radiology, The Royal Marsden Hospital, 203 Fulham Rd, London, SW3 6JJ, England, UK.
  • Sharma B; Department of Radiology and Nuclear Medicine, Imperial College Healthcare NHS Trust, Fulham Palace Rd, London, W6 8RF, England, UK.
  • McGrath SE; Department of Nuclear Medicine, The Royal Marsden Hospital, 203 Fulham Rd, London, SW3 6JJ, England, UK.
  • Okines AF; Department of Radiology and Nuclear Medicine, The Royal Marsden Hospital, 203 Fulham Rd, London, SW3 6JJ, England, UK.
  • Ring AE; Department of Medicine - Breast Unit, The Royal Marsden Hospital, Downs Rd, Sutton, SM2 5PT, England, UK.
  • Messiou C; Department of Medicine - Breast Unit, The Royal Marsden Hospital, 203 Fulham Rd, London, SW3 6JJ, England, UK.
  • Downey K; Department of Medicine - Breast Unit, The Royal Marsden Hospital, Downs Rd, Sutton, SM2 5PT, England, UK.
  • Koh DM; Department of Radiology, The Royal Marsden Hospital, Downs Rd, Sutton, SM2 5PT, England, UK.
Cancer Imaging ; 22(1): 26, 2022 Jun 07.
Article em En | MEDLINE | ID: mdl-35672838
BACKGROUND: The assessment of metastatic breast cancer (MBC) can be limited with routine imaging such as computed tomography (CT) especially in bone-only or bone-predominant disease. This analysis investigates the effects of the use of WBMRI in addition to the use of routine CT, bone scintigraphy (BS) and fluorine-18-fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET/CT) on influencing systemic anti-cancer treatment (SACT) decisions in patients with known MBC. METHODS: MBC patients undergoing SACT who had WBMRI undertaken within 8 weeks of either a routine CT, BS or FDG-PET/CT were reviewed retrospectively. The clinical indications for undertaking the WBMRI examinations were recorded. Data on the extent and distribution of the disease were collected and discordance/concordance of disease status across the imaging modalities were compared. SACT decisions at each time point were also evaluated. RESULTS: There were 105 MBC patients with 148 WBMRI studies paired with CT, BS or FDG-PET/CT. 50 pairs (33.8%) showed differences in the extent of disease, with 44 pairs due to additional sites (AS) reported on WBMRI alone. 81 patients (Group 1) had one WBMRI paired with routine imaging due to a variety of indications, with clinical symptoms (such as bone pain) being the most common (24.7%). 24 patients (Group 2) had more than one WBMRI study paired with routine imaging comprising 67 pairs. 13/67 pairs (19.4%) showed discordance in assessments. 10/13 pairs had progressive disease (PD) reported on WBMRI alone. SACT change due to AS reported on WBMRI alone occurred in 21/23 pairs (91.3%) in Group 1. SACT change due to PD reported on WBMRI alone in Group 2 occurred in 6/14 pairs (42.9%). SACT change due to AS/PD in both groups occurred in 11/102 pairs (10.8%) with known invasive ductal carcinoma (IDC) and 13/28 pairs (46.4%) with invasive lobular carcinoma (ILC). CONCLUSIONS: The use of WBMRI in MBC led to earlier recognition of PD and SACT change compared with the other imaging modalities. A higher proportion of discordant response assessments and SACT changes were observed in ILC compared with IDC in our patient group, although larger-scale studies are required to investigate this further.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Fluordesoxiglucose F18 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Imaging Assunto da revista: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Fluordesoxiglucose F18 Tipo de estudo: Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Imaging Assunto da revista: DIAGNOSTICO POR IMAGEM / NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article